Get the Stockscreener App
1.98
15.12%
0.26
China Sxt Pharmaceuticals Inc stock is traded at $1.98, with a volume of 439.94K.
It is up +15.12% in the last 24 hours and up +26.92% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$1.72
Open:
$1.7
24h Volume:
439.94K
Relative Volume:
1.42
Market Cap:
$229.73M
Revenue:
$1.93M
Net Income/Loss:
$-3.10M
P/E Ratio:
-0.121
EPS:
-16.3657
Net Cash Flow:
$-1.93M
1W Performance:
+22.98%
1M Performance:
+26.92%
6M Performance:
-36.33%
1Y Performance:
-62.50%
1-Day Range:
$1.5801
$2.07
1-Week Range:
$1.332
$2.07
52-Week Range:
$0.95
$7.84
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.98 | 162.44M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
Analyzing China SXT Pharmaceuticals Inc. with multi timeframe chartsQuarterly Market Review & Community Supported Trade Ideas - Newser
Applying big data sentiment scoring on China SXT Pharmaceuticals Inc.July 2025 Highlights & Risk Managed Investment Strategies - Newser
Is China SXT Pharmaceuticals Inc. stock ready for a breakout2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Momentum divergence signals in China SXT Pharmaceuticals Inc. chartJuly 2025 Volume & Growth Focused Stock Reports - Newser
Chart based analysis of China SXT Pharmaceuticals Inc. trendsDip Buying & Free Reliable Trade Execution Plans - Newser
China SXT Pharmaceuticals Inc. stock volume spike explainedRecession Risk & AI Forecast Swing Trade Picks - Newser
What’s the recovery path for long term holders of China SXT Pharmaceuticals Inc.2025 Momentum Check & Real-Time Market Trend Scan - Newser
Should you wait for a breakout in China SXT Pharmaceuticals Inc.Weekly Trend Summary & Community Consensus Stock Picks - Newser
Relative strength of China SXT Pharmaceuticals Inc. in sector analysisPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Will breakout in China SXT Pharmaceuticals Inc. lead to full recovery2025 Stock Rankings & Expert Curated Trade Ideas - Newser
What machine learning models say about China SXT Pharmaceuticals Inc.July 2025 Big Picture & Community Consensus Trade Signals - Newser
Using data filters to optimize entry into China SXT Pharmaceuticals Inc.2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
Published on: 2025-09-11 23:21:41 - Newser
Technical signs of recovery in China SXT Pharmaceuticals Inc.Market Sentiment Summary & Accurate Buy Signal Alerts - Newser
momentum divergence signals in china sxt pharmaceuticals inc. chart2025 EndofYear Setup & Step-by-Step Swing Trade Plans - Newser
How to manage a losing position in China SXT Pharmaceuticals Inc.2025 Biggest Moves & Short-Term Trading Opportunity Alerts - Newser
Applying Wyckoff theory to China SXT Pharmaceuticals Inc. stock2025 Market Outlook & AI Driven Stock Movement Reports - Newser
Live market analysis of China SXT Pharmaceuticals Inc.Trade Exit Summary & Community Consensus Trade Signals - Newser
Should you hold or exit China SXT Pharmaceuticals Inc. nowBond Market & Safe Capital Investment Plans - Newser
Visualizing China SXT Pharmaceuticals Inc. stock with heatmapsMarket Sentiment Summary & Smart Investment Allocation Tips - Newser
Can machine learning forecast China SXT Pharmaceuticals Inc. recovery2025 Historical Comparison & Reliable Intraday Trade Plans - Newser
Market reaction to China SXT Pharmaceuticals Inc.’s recent newsShort Setup & Accurate Buy Signal Alerts - Newser
| MarketBeat - MarketBeat
Using Ichimoku Cloud for China SXT Pharmaceuticals Inc. technicalsPortfolio Update Report & Low Risk Investment Opportunities - Newser
What institutional flow reveals about China SXT Pharmaceuticals Inc.Quarterly Investment Review & Fast Moving Trade Plans - Newser
Has China SXT Pharmaceuticals Inc. found a price floor2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser
Published on: 2025-09-10 11:06:32 - Newser
Best data tools to analyze China SXT Pharmaceuticals Inc. stockWeekly Market Outlook & Accurate Intraday Trade Tips - Newser
Published on: 2025-09-10 01:03:52 - Newser
Will China SXT Pharmaceuticals Inc. bounce back from current supportWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser
Chart based exit strategy for China SXT Pharmaceuticals Inc.Volume Spike & Comprehensive Market Scan Insights - Newser
Published on: 2025-09-09 06:19:08 - Newser
is china sxt pharmaceuticals inc. trending in predictive chart models2025 Market Overview & AI Forecast for Swing Trade Picks - Newser
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):